AstraZeneca And Rigel Sign Worldwide License Agreement For A ... MarketWatch (press release) ... JAK/SYK inhibitor for discoid lupus; and R548, an oral JAK3 inhibitor for the treatment of transplant rejection and other immune disorders. www.rigel.com ... |
